Sort
23,748 grants matching “melanoma”
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside
$334,125Xianglin Shi · University Of Kentucky · R01 · FY2015 · ES
Host defense against respiratory virus infections
$334,125Santanu Bose · University Of Texas Hlth Science Center · R01 · FY2010 · AI
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside
$334,125Xianglin Shi · University Of Kentucky · R01 · FY2012 · ES
Drug Development of Ribonucleotide Reductase Inhibitor
$334,117Yun Yen · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA
Drug Development of Ribonucleotide Reductase Inhibitor
$334,117David A. Horne · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention
$334,113Mohammad Athar · University Of Alabama At Birmingham · R01 · FY2010 · ES
Mechanisms of photocarcinogenesis in geriatric skin
$334,102Dan F Spandau · Indiana University Indianapolis · R01 · FY2013 · ES
Hypoxia and Gene Repression
$334,079Amato J. Giaccia · Stanford University · R37 · FY2010 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2011 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2015 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$334,075Kenneth P Olive · Columbia University Health Sciences · R01 · FY2012 · CA
GAB2 in metastatic melanoma
$333,954Julide T Celebi · Columbia University Health Sciences · R01 · FY2010 · CA
Investigating p16 Loss in Pro-tumorigenic Metabolism
$333,898Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R37 · FY2024 · CA
Estrogen receptor beta is a targetable melanoma tumor suppressor
$333,894Craig J Burd · Ohio State University · R01 · FY2024 · CA
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer
$333,825Thomas E. Carey · University Of Michigan At Ann Arbor · R01 · FY2011 · DE
Role of HOS in Cell Transformation and Apoptosis
$333,813Serge Y Fuchs · University Of Pennsylvania · R01 · FY2019 · CA
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
$333,775Richard Heller · University Of South Florida · R01 · FY2008 · CA
Murine & Human In Vivo Models of Melanoma Formation
$333,709Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · P01 · FY2007 · ES
Measuring real time decision-making about UVR Protection
$333,696Jennifer L Hay · Sloan-Kettering Inst Can Research · R21 · FY2009 · CA
Pathways from genotype and environment to melanoma
$333,687Queensland Institute Of Medical Research · R01 · FY2003 · CA
Adoptive CD4 T Cell Therapy of Melanoma
$333,632Fred Hutchinson Cancer Research Center · R21 · FY2001 · CA
Radiation Affects Tumor Antigen Presentation
$333,619William H. McBride · University Of California Los Angeles · R01 · FY2006 · CA
Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors
$333,602John H Sampson · Duke University · P50 · FY2017 · CA
Project 3: Identifying transcriptional driver genes and targeting transcription in TSC
$333,541David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2019 · CA
Personalized targeting of anti-apoptosis pathways to overcome therapeutic resistance in melanoma
$333,518Michael Davies · Wistar Institute · U54 · FY2025 · CA